Exxon Mobil Corp (NYSE: XOM) anticipates a decrease in second-quarter earnings by roughly $4 billion due to lower natural gas prices and refining margins.
Teva Pharmaceutical Industries Ltd (NYSE: TEVA) is reportedly considering potential strategic options for its active pharmaceutical ingredients (API) unit, which could include a potential sale.
Moderna Inc (NASDAQ: MRNA) reportedly struck a deal with Chinese authorities to research, develop, and manufacture messenger RNA (mRNA) medicines in the country.